DocGo Inc. Increase (Decrease) in Accrued Liabilities
DocGo Inc. (DCGO) reported Increase (Decrease) in Accrued Liabilities of -$2.52 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-17
- DocGo Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$4.46M, a 362.81% decline year-over-year.
- DocGo Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $1.94M.
- DocGo Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$7.73M.
- DocGo Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $4.78M.
- DocGo Inc. increase (decrease) in accrued liabilities for fiscal 2025 was -$10.40M.
- DocGo Inc. increase (decrease) in accrued liabilities for fiscal 2024 was -$41.94M, a 171.12% decline from fiscal 2023.
- DocGo Inc. increase (decrease) in accrued liabilities for fiscal 2023 was $58.97M.
- DocGo Inc. increase (decrease) in accrued liabilities for fiscal 2022 was -$5.96M, a 128.72% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | -$2.52M 10-Q · filed 2026-08-17 | -$10.25M derived: sum of 3 quarters · filed 2026-08-17 | -$5.47M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $1.94M 10-Q · filed 2026-05-11 | -$5.79M derived: sum of 2 quarters · filed 2026-05-11 | -$1.01M derived: sum of 3 quarters · filed 2026-05-11 | $685.59K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | -$7.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$2.95M derived: sum of 2 quarters · filed 2026-03-16 | -$1.25M derived: sum of 3 quarters · filed 2026-08-17 | -$10.40M 10-K · filed 2026-03-16 |
| 2025-09-30 | $4.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $6.48M derived: sum of 2 quarters · filed 2026-08-17 | -$2.67M 10-Q · filed 2025-11-10 | -$13.12M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | -$7.45M 10-Q · filed 2026-08-17 | -$17.90M derived: sum of 3 quarters · filed 2026-08-17 | -$21.40M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | -$9.15M 10-Q · filed 2026-05-11 | -$19.59M derived: sum of 2 quarters · filed 2026-05-11 | -$23.09M derived: sum of 3 quarters · filed 2026-05-11 | -$30.28M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$10.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$13.94M derived: sum of 2 quarters · filed 2026-03-16 | -$21.13M derived: sum of 3 quarters · filed 2026-03-16 | -$41.94M 10-K · filed 2026-03-16 |
| 2024-09-30 | -$3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$10.69M derived: sum of 2 quarters · filed 2025-11-10 | -$31.50M 10-Q · filed 2025-11-10 | $154.07K derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | -$7.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$28.00M 10-Q · filed 2025-08-07 | $3.65M derived: sum of 3 quarters · filed 2026-03-16 | $29.77M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | -$20.81M 10-Q · filed 2025-05-08 | $10.84M derived: sum of 2 quarters · filed 2026-03-16 | $36.96M derived: sum of 3 quarters · filed 2026-03-16 | $39.63M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $31.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $57.77M derived: sum of 2 quarters · filed 2026-03-16 | $60.44M derived: sum of 3 quarters · filed 2026-03-16 | $58.97M 10-K · filed 2026-03-16 |
| 2023-09-30 | $26.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $28.79M derived: sum of 2 quarters · filed 2024-11-07 | $27.32M 10-Q · filed 2024-11-07 | $18.76M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $2.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $1.20M 10-Q · filed 2024-08-07 | -$7.36M derived: sum of 3 quarters · filed 2025-02-27 | -$8.31M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$1.47M 10-Q · filed 2024-05-08 | -$10.03M derived: sum of 2 quarters · filed 2025-02-27 | -$10.98M derived: sum of 3 quarters · filed 2025-02-27 | -$10.50M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$8.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$9.51M derived: sum of 2 quarters · filed 2025-02-27 | -$9.03M derived: sum of 3 quarters · filed 2025-02-27 | -$5.96M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$948.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$466.26K derived: sum of 2 quarters · filed 2023-11-06 | $2.60M 10-Q · filed 2023-11-06 | -$1.50M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $482.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $3.55M 10-Q · filed 2023-08-08 | -$549.44K derived: sum of 3 quarters · filed 2024-02-28 | $11.98M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $3.06M 10-Q · filed 2023-05-09 | -$1.03M derived: sum of 2 quarters · filed 2024-02-28 | $11.50M derived: sum of 3 quarters · filed 2024-02-28 | $15.93M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $8.44M derived: sum of 2 quarters · filed 2024-02-28 | $12.86M derived: sum of 3 quarters · filed 2024-02-28 | $20.77M 10-K · filed 2024-02-28 |
| 2021-09-30 | $12.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $16.96M derived: sum of 2 quarters · filed 2022-11-08 | $24.86M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $4.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $12.33M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $7.90M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $9.67M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |